mycophenolic-acid has been researched along with Hypokalemia* in 2 studies
2 other study(ies) available for mycophenolic-acid and Hypokalemia
Article | Year |
---|---|
Hypokalaemic paralysis secondary to distal renal tubular acidosis as the presenting symptom of systemic lupus erythematosus.
We report hypokalaemic quadriparesis presenting in a 43-year-old woman. Evaluation revealed hypokalaemic quadriparesis secondary to underlying distal renal tubular acidosis, also known as type 1 RTA. Four years after the diagnosis of RTA, the patient developed joint pain, and investigation revealed systemic lupus erythematosus with lupus nephritis. RTA is one of the very rare presentations of systemic lupus erythematosus. Thus, tubular dysfunction should be carefully assessed in patients with systemic lupus erythematosus. Similarly, patients with RTA should be evaluated for underlying lupus. Our patient was successfully treated with mycophenolate mofetil and steroids. Topics: Acidosis, Renal Tubular; Acute Disease; Adult; Blood Sedimentation; Female; Humans; Hypokalemia; Lupus Erythematosus, Systemic; Muscles; Mycophenolic Acid; Paralysis; Proteinuria; Steroids; Treatment Outcome | 2011 |
Hypokalemic paralysis as primary presentation of Fanconi syndrome associated with Sjögren syndrome.
Hypokalemic paralysis is a rare presentation of Fanconi syndrome (FS) caused by Sjögren Syndrome (SS). We describe a 39-year-old man who manifested flaccid paralysis of 4 limbs. Laboratory investigations showed profound hypokalemia (1.6 mmol/L) with renal K wasting, hyperchloremic metabolic acidosis with positive urine anion gap, hypophosphatemia with hyperphosphaturia, hypouricemia with hyperuricosuria, normoglycemic glycosuria, and abnormal serum creatinine concentration 2.2 mg/dL. A thorough survey for the cause of FS revealed that he had xerophthalmia and xerostomia accompanied by high anti-Ro antibody, positive Schirmer test, and delayed saliva excretion on sialoscintigraphy, confirming the diagnosis of SS. Potassium citrate, active vitamin D3, and high phosphate diet for his FS coupled with mycophenolate mofetil for SS resolved clinical symptoms and ameliorated renal function. Early recognition of HP due to the underlying SS-related FS with prompt therapy not only could terminate potentially life-threatening hypokalemia, but also improve renal outcome. Topics: Adult; Antirheumatic Agents; Fanconi Syndrome; Humans; Hypokalemia; Male; Muscle Hypotonia; Mycophenolic Acid; Paralysis; Sjogren's Syndrome | 2010 |